BKSE
BNY Mellon US Small Cap Core Equity ETF
BKSE tracks a market-cap weighted index of US small-cap stocks that covers the bottom 3-10% capitalization.
US
EQUITY
Passive
MANAGEMENT STYLE
$ 62.6 M
ASSETS UNDER MGMT
4 bp
EXPENSES
Fund Basics
| Inception date | Apr 09, 2020 |
| Regulation | Open-Ended Fund |
| Fund Website | link... |
| Distributions | Quarterly |
| Currency | USD |
| Holdings Transparency | Full |
| Derivatives-based | No |
| Options available | No |
| Currency hedged | No |
| Fund of funds | No |
Top 10 Holdings
| CRANE HOLDINGS, CO. | 0.4 % |
| AVIDITY BIOSCIENCES INC | 0.4 % |
| CARETRUST REIT INC | 0.4 % |
| AMERICAN HEALTHC | 0.4 % |
| ARROWHEAD PHARMACEUTICALS, INC. | 0.4 % |
| AFFILIATED MANAGERS GROUP | 0.4 % |
| SANMINA CORP | 0.4 % |
| COMMERCIAL METALS CO | 0.4 % |
| JOHN BEAN TECHNOLOGIES CORP | 0.4 % |
| ADVANCED ENERGY INDUSTRIES | 0.4 % |
Constituent Breakdown
| Number of holdings | 602 |
| Herfindahl-Hirschman Index | 20 |
| Wgt avg mkt cap (mns) | $4,160 |
| Large cap (>$10bn) | 0.4% |
| Mid cap ($2-10bn) | 88.5% |
| Small cap (<$2bn) | 2.8% |
| Developed mkts. | 94.2% |
| Emerging mkts. | 0.3% |
Sector Breakdown
Country Exposure
 |
UNITED STATES | 91.2 % |
 |
BERMUDA | 0.9 % |
 |
BRITAIN | 0.8 % |
Historical Performance
Standardized Performance (as of 03/31/2026)
| YTD | 1 YR | 2 YR | 3 YR | 5 YR | 10 YR | 20 YR | Incep. | |
|---|---|---|---|---|---|---|---|---|
| Price Returns | 1.3% | 22.1% | 8.9% | 11.9% | 3.9% | -- | -- | 13.1% |
| Dividend Yield | 0.0% | 1.7% | 1.6% | 1.7% | 1.5% | -- | -- | 1.5% |
| Total Returns | 1.3% | 23.8% | 10.5% | 13.6% | 5.4% | -- | -- | 14.7% | Ann. Volatility | 19.5% | 22.9% | 21.0% | 20.2% | 21.5% | -- | -- | 22.5% |
Market Correlations
| versus... | Beta | R-squared |
| S&P 500 | 1.05 | 76% |
| MSCI EAFE | 0.97 | 56% |
| MSCI Emg Mkts | 0.78 | 48% |
Liquidity Measures
| Avg. volume (000) | 2 |
| ADV traded (mns) | $0 |
| Turnover | 0.4% |
| Avg. Bid/Ask (% of price) | 0.12% |
Technical Indicators
| 30d moving avg. (EMA) | $115.61 |
| Relative strength (RSI) | 55 |
| MACD/Signal | 0.54/-0.42 |
| Bollinger Bands (Upper/Lower) | $119.25/$108.97 |
| Short interest (% of AUM) | 0.1% |
Distributions
Top Ten Comparable ETFs only shown here. For an extended list become an Individual or Professional subscriber. Start your FREE trial
Comparable ETFs Based on Overlap
| Ticker | Fund Name | Overlap vs. BKSE |
Expenses vs. BKSE |
ALTAR Score™ vs. BKSE |
|---|---|---|---|---|
| STXK | Strive Small-Cap ETF | 67.3% | +14 bp | -0.1% |
| JHSC | John Hancock Multifactor Small Cap ETF | 61.6% | +38 bp | +0.7% |
| BBSC | JPMorgan BetaBuilders U.S. Small Cap Equity ETF | 53.1% | +5 bp | -1.5% |
| TPSC | Timothy Plan US Small Cap Core ETF | 51.3% | +48 bp | +1.3% |
| CSA | VictoryShares US Small Cap Volatility Wtd ETF | 51.2% | +31 bp | +1.2% |
| RSSL | Global X Russell 2000 ETF | 47.3% | +4 bp | -2.6% |
| IWM | iShares Russell 2000 ETF | 46.2% | +15 bp | -2.7% |
| OMFS | Invesco Russell 2000 Dynamic Multifactor ETF | 43.5% | +35 bp | -1.7% |
| SPSM | State Street SPDR Portfolio S&P 600 Small Cap ETF | 42.7% | -1 bp | +1.1% |
| IJR | iShares Core S&P Small Cap ETF | 42.5% | +2 bp | +1.1% |
Risk and Returns: BKSE vs. Comps (1 YR)
Notes: Top 10 overlapping ETFs. Funds with insufficient history not shown. Some funds may overlap. Hover over data point for ticker symbol.
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Results & Estimates (USD)
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|---|---|
| Sales per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Earnings per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Dividends per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- | ||
| Book value per share | -- | -- | -- | -- | -- | -- | -- | ||
| change (%) | -- | -- | -- | -- | -- | -- | -- |
Return on Equity
Net Margins
Content on this tab for Individual & Professional subscribers only. Start your FREE trial
Valuation Metrics
| Fwd Est | 2025 | 2026 | 2027 | |
| Price-to-sales | --x | --x | --x | --x |
| Price-to-earnings | --x | --x | --x | --x |
| Price-to-cash flow | --x | --x | --x | --x |
| Price-to-growth | --x | --x | --x | --x |
| Price-to-book value | --x | --x | --x | --x |
| Yield | --% | --% | --x | --% |
Based on closing prices from 4/12/2026
Peer Group Comparison Sample data. Subscribe for access.
Price-to-Earnings
Price-to-Sales
Price-to-Book Value
Price-to-Cash Flow
Price-to-Growth
Dividend Yield
Historical Valuation Trends Sample data. Subscribe for access.
SHOWING:
Price-to-Earnings
Price-to-Earnings
Notes: Based on adjusted historical results for current fund constituents. May differ from results achieved by past fund constituents. Max P/E of 100x.
Some content on this tab for Individual & Professional subscribers only. Start your FREE trial
ETF Research Center Rating
6.0%
ALTAR SCORE™
57th
PERCENTILE
NEUTRAL
ETFRC RATING
There are 1,201 funds in the US Equity category with an average
ALTAR Score™ of 5.6% and a standard deviation
of 2.1%. BKSE's ALTAR Score™ is approximately 0.2 standard
deviations above the category average. This places BKSE in the 57th percentile
among funds in the category.
Sell-Side Consensus
$145.23
PRICE TARGET
+22.1%
UPSIDE